• Velocity® System
  • About Us
  • Our Team
  • Clinical Study
  • News & Events
  • Contact Us

Secondary interventions to assist pAVF maturation remain commonplace for current endoAVF devices

Jul 3, 2023

While currently available percutaneous arteriovenous fistula (pAVF) devices have demonstrated a high rate of technical procedural success, secondary interventions are often required to achieve fistula maturation with these devices. CLICK HERE to read an excellent...

Robert Shahverdyan, MD presents insights from initial clinical experience with the Velocity System during Charing Cross (CX) Symposium

May 8, 2023

During the recent Charing Cross (CX) International Symposium held in London, Robert Shahverdyan, MD detailed the challenges associated with the use of current endovascular arteriovenous fistula (endoAVF) devices and provided insights from his clinical experience with...
Next Entries »

CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use.

Disclaimer:  Venova Medical, Inc. does not currently offer medical devices for sale or distribution and the company’s technology has not received market clearance status by the U.S. FDA or any other country’s regulatory authority.



649 University Ave. Los Gatos, CA 95032



408.242.5897



info@venovamed.com

Follow Us

  • Follow

Get in Touch

15 + 6 =

© 2025 Venova Medical, Inc. All Rights Reserved.

MKT0350.D